Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New IGF-I receptor inhibitors reported by Boehringer Ingelheim

July 25, 2012

Eutropics Pharmaceuticals discloses novel Mcl-1/Bcl-XL inhibitors

July 25, 2012

Researchers at Leo Pharma patent novel ingenol compounds

July 25, 2012

Treatment begins in phase II trial of Cerulean's lead product

July 24, 2012

CHMP issues opinion on Dacogen

July 24, 2012

Celgene to request reexamination of CHMP opinion on Istodax MAA

July 24, 2012

Antisense Therapeutics provides update on ATL-1101

July 24, 2012

Gene Signal International discloses novel agents for cancer

July 24, 2012

Korean researchers present new siRNA compositions

July 24, 2012

FDA approves Afinitor in combination with exemestane in advanced breast cancer

July 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...